Budimex SA

Becton Dickinson and Company, also known as BD, is a leading global medical technology company that specializes in the development, manufacturing, and sale of medical devices, instrument systems, and reagents. Established in 1897 and headquartered in Franklin Lakes, New Jersey, USA, BD operates in three business segments: BD Medical, BD Life Sciences, and BD Interventional. BD Medical offers a wide range of medical devices and products, including syringes, needles, infusion therapy, and diabetes care. BD Life Sciences provides products and services for the research, clinical, and industrial markets, including cell analysis, microbiology, and molecular diagnostics. BD Interventional offers products and services for the treatment of vascular diseases, cancer, and other conditions. With operations in over 50 countries and sales in more than 190 countries, BD has a strong global presence and a workforce of approximately 70,000 employees worldwide. The company is committed to improving healthcare outcomes through innovative solutions and has a long history of innovation, receiving numerous awards and recognitions for its contributions to the healthcare industry. BD is dedicated to improving the quality of life for people around the world and is committed to sustainability and corporate responsibility, setting ambitious goals to reduce its environmental impact and promoting diversity, equity, and inclusion in the workplace.